fda semaglutide ban Weight Loss Wednesday: Low-cost weight loss drug banned in La US judge upholds FDA's removal

Understanding how long tirzepatide diarrhea lasts helps set realistic expectations

Some patients benefit from extending the gap between doses rather than reducing dose size

With the FDAs approval of the first-ever oral GLP1 for weight loss, Novo Nordisk has secured a strategic advantage in one of the fastestgrowing therapeutic categories

Should retatrutide receive a positive regulatory decision, it would then be subject to a health technology appraisal (HTA) by NICE (National Institute for Health and Care Excellence) to determine its clinical and cost-effectiveness relative to existing treatments

No, you do not have to give up coffee

Gala GLP-1 is a telehealth platform